COVID-19 Clinical Trials in San Francisco, California
5 recruitingSan Francisco, California
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID)140 enrolled8 locationsNCT07221162
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 1Phase 2
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
COVID-19
Kara Chew80 enrolled2 locationsNCT06810934
Recruiting
Not Applicable
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
COVID-19Long COVID
University of California, San Francisco20 enrolled1 locationNCT05530317
Recruiting
Neural and Cognitive Consequences of COVID-19 Survival
COVID-19COVID Long-Haul
San Francisco Veterans Affairs Medical Center150 enrolled1 locationNCT06208943